Skip to content
OpenCapital
Get started

Intensity Therapeutics, Inc. INTS Q3 2025 earnings

Reported November 6, 2025 · Before market open

EPS-$0.06In line
EPS estimate-$0.06

Next report

Aug 6, 2026 (In 1 week)
EPS estimate-$0.87

Versus estimates

Diluted EPS

Q1 2026-$0.96Beat by $0.23Q4 2025$1.69Beat by $2.93
Q3 2025-$0.06In line
Q2 2025-$0.13Miss by $0.07Q1 2025-$0.22Miss by $0.01Q4 2024-$0.22Beat by $0.01

Ask the moment Intensity Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Intensity Therapeutics, Inc. report Q3 2025 earnings?
Intensity Therapeutics, Inc. (INTS) reported Q3 2025 earnings on November 6, 2025 before market open.
What were Intensity Therapeutics, Inc.'s Q3 2025 revenue and EPS?
Intensity Therapeutics, Inc. reported eps of $-0.06 for Q3 2025.
Did Intensity Therapeutics, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.06 by $0.00.
How did Intensity Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 76.0% from $-0.25.
Where can I find Intensity Therapeutics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001567264-25-000104) and the 10-Q periodic report (0001567264-25-000103) directly on SEC EDGAR. The filing index links above go to sec.gov.